Invention Grant
- Patent Title: Method for predicting the risk of deep vein thrombosis and pulmonary embolism associated with hormonal preparations and hormone levels
-
Application No.: US16468074Application Date: 2017-12-11
-
Publication No.: US11377692B2Publication Date: 2022-07-05
- Inventor: Goranka Tanackovic Abbas-Terki , Joëlle Michaud Schutz , Thierry Daniel Pache
- Applicant: GENE GENDER S.R.L.
- Applicant Address: IT Milan
- Assignee: GENE GENDER S.R.L.
- Current Assignee: GENE GENDER S.R.L.
- Current Assignee Address: IT Milan
- Agency: Oliff PLC
- Priority: EP16203286 20161209,EP17163897 20170330
- International Application: PCT/EP2017/082164 WO 20171211
- International Announcement: WO2018/104549 WO 20180614
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/6883

Abstract:
Specific single nucleotide polymorphisms (SNPs) in the human genome, and their association with deep vein thrombosis (DVT) and related pathologies, such as pulmonary embolism (PE), in relation with hormonal preparations (i.e. combined contraceptives, hormone replacement therapeutics) and hormone levels (i.e. during pregnancy and post-partum).
Public/Granted literature
Information query